Premium
Role of tryptophan metabolites in the hypoglycemia associated with neoplasia
Author(s) -
Silverstein Murray N.,
Wakim Khalil G.,
Bahn Robert C.,
Decker Richard H.
Publication year - 1966
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(196601)19:1<127::aid-cncr2820190114>3.0.co;2-5
Subject(s) - tryptophan , urine , indole test , hypoglycemia , endocrinology , kynurenic acid , medicine , tryptophan metabolism , chemistry , biochemistry , amino acid , insulin
Three patients who had hypoglycemia associated with neoplasia were studied. In one, total tryptophan and protein‐free metabolites of tryptophan in blood and tryptophan metabolites in urine were increased during hypoglycemia. In another, total tryptophan and protein‐free tryptophan metabolites in serum were increased markedly and tryptophan metabolites in urine were increased mostly during hypoglycemia; during normoglycemia, however, concentration of both total tryptophan and protein‐free tryptophan metabolites in serum and of protein‐free tryptophan metabolites in urine was mostly normal. In the third, during normoglycemia, concentrations of total tryptophan and protein‐free tryptophan metabolites in serum and of protein‐free tryptophan metabolites in urine were normal or nearly so. Thus, patients with hypoglycemia associated with neoplasia seemingly have increased concentrations of tryptophan and tryptophan metabolites in serum and urine during hypoglycemic periods. Intraperitoneal administration of indole‐3‐propionic acid, indole‐3‐butyric acid, and indole‐3‐aretic acid caused profound hypoglycemia in normal and alloxandiabetic mice while L‐tryptophan and kynurenic acid had no effect.